# Optimized Intensity Modulated Irradiation for Head and Neck Cancer

> **NCT00580983** · NA · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 90 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** IMRT
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** 5-Fluorouracil

## Key facts

- **NCT ID:** NCT00580983
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580983, "Optimized Intensity Modulated Irradiation for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00580983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*